A detailed history of Caption Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Caption Management, LLC holds 60,326 shares of ALKS stock, worth $1.86 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
60,326
Previous 30,000 101.09%
Holding current value
$1.86 Million
Previous $723,000 133.47%
% of portfolio
0.03%
Previous 0.01%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.01 - $28.55 $1.39 Million - $1.72 Million
60,326 New
60,326 $1.69 Million
Q3 2023

Nov 14, 2023

BUY
$27.17 - $31.97 $1.77 Million - $2.08 Million
65,214 New
65,214 $1.83 Million
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $4.04 Million - $4.9 Million
-175,000 Reduced 62.5%
105,000 $2.76 Million
Q4 2021

Feb 11, 2022

SELL
$21.47 - $32.08 $1.38 Million - $2.06 Million
-64,100 Reduced 18.63%
280,000 $6.51 Million
Q3 2021

Nov 12, 2021

SELL
$23.37 - $32.13 $1.34 Million - $1.84 Million
-57,153 Reduced 14.24%
344,100 $10.6 Million
Q2 2021

Aug 16, 2021

SELL
$18.78 - $25.15 $1.2 Million - $1.6 Million
-63,747 Reduced 13.71%
401,253 $9.84 Million
Q1 2021

May 17, 2021

BUY
$18.21 - $23.2 $3.95 Million - $5.03 Million
216,715 Added 87.28%
465,000 $8.69 Million
Q4 2020

Feb 16, 2021

SELL
$15.39 - $22.1 $1.49 Million - $2.14 Million
-96,715 Reduced 28.03%
248,285 $4.95 Million
Q3 2020

Nov 16, 2020

BUY
$16.16 - $20.66 $955,152 - $1.22 Million
59,106 Added 20.67%
345,000 $5.72 Million
Q2 2020

Aug 14, 2020

BUY
$13.31 - $19.41 $3.81 Million - $5.55 Million
285,894 New
285,894 $5.55 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.05B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.